ArticleMicrobiology spectrum2026
Risk factors for
Chien Chuang, Szu-Yu Liu, Yu-Chien Ho, Sheng-Hua Chou, Yi-Ru Huang, Wan Chin, Hsiang-Ling Ho, Liang Chen, Yi-Tsung Lin
Abstract read
In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Chien ChuangDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Szu-Yu LiuDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Yu-Chien HoDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Sheng-Hua ChouDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Yi-Ru HuangDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Wan ChinDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Hsiang-Ling HoDepartment of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Liang ChenDepartment of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA.
Yi-Tsung LinDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.ORCID 0000-0001-9940-7529 Funding
Ministry of Science and Technology, taiwan 111-2314-B-A49-044National Science and Technology Council 112-2314-B-A49-029, 114-2314-B-A49-079-MY3Taipei Veterans General Hospital V112C-102, V113C-073, V114C-047
6 · The paper itselfAbstract
The emergence of ceftazidime-avibactam-resistant
Indexed as
Azabicyclo Compoundsbeta-Lactamase InhibitorsCeftazidimeDrug Resistance, Multiple, BacterialKlebsiella InfectionsKlebsiella pneumoniaeThird Generation CephalosporinsAgedAged, 80 and overAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCase-Control StudiesDrug CombinationsFemaleHumansAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsBacterial Proteinsbeta-Lactamase Inhibitorsbeta-LactamasescarbapenemaseCeftazidimeDrug CombinationsThird Generation Cephalosporinsceftazidime-avibactamKlebsiella pneumoniaeKPCresistancerisk factor
Identifiers
PMID42080564
PMCPMC13227984
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390